Biosimilars Market Expected To Be Worth US$ 9.5 Billion By 2022

Florida, January 22, 2018: The Global Biosimilars Market is expected to exceed more than US$ 9.5 billion by 2022 and will grow at a CAGR of more than 26% in the given forecast period.

The Global Biosimilars Market is segmented on the lines of its product, application and regional. Based on product segmentation it covers recombinant nonglycosylated proteins, recombinant peptides and recombinant glycosylated proteins. Under application segmentation it covers oncology, blood disorders, growth hormone deficiency, chronic and sutoimmune diseases and infectious diseases. The Global biosimilars Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

Browse the full report here: https://www.marketresearchengine.com/biosimilars-market-report

The major driving factors of Global Biosimilars Market are as follows:
• Increasing force to curtail healthcare expenditure
• Increasing incidences of diseases
• Rising demand for biosimilars drug due to itscost effectiveness
• Increase in aging population
• Growing government support and initiative to expand and support biosimilars

The restraining factors of Global Biosimilars Market are as follows:
• High manufacturing complexity and expenditure
• Inventive strategies by biologic drug manufacturer

This report provides:

1) An overview of the global market for Biosimilars and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Biosimilars Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

REPORT SCOPE:

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sandoz International GmbH (Germany), Hospira, Inc. (U.S.), and Teva Pharmaceutical Industries Ltd. (Israel), Dr. Reddy’s Laboratories (India), Biocon Limited (India), Mylan, Inc.(U.S.), Amgen (U.S.), Celltrion Inc. (South Korea), Roche Diagnostics (Switzerland), and Merck KGaA (Germany). Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The scope of the report includes a detailed study of global and regional markets for Global Biosimilars Market with the reasons given for variations in the growth of the industry in certain regions.

Request Sample Report: https://www.marketresearchengine.com/biosimilars-market-report

Table of Contents
1 INTRODUCTION
2 Research Methodology
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Biosimilars Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Biosimilars Market Breakdown & Data Triangulation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biosimilars Market, By Type of Product
7 Biosimilars Market, By Type of Manufacturing
8 Biosimilars Market, By Application
9 Biosimilars Market, By Region
10 Competitive Landscape
11 Company Profiles
11.1 Introduction
11.2 Pfizer Inc.
11.3 Sandoz International GmbH (A Division of Novartis International AG)
11.4 Teva Pharmaceutical Industries Ltd.
11.5 F. Hoffmann-La Roche Ltd.
11.6 Amgen Inc.
11.7 Biocon Ltd.
11.8 Dr. Reddy's Laboratories
11.9 Celltrion Inc.
11.10 Mylan Inc.
11.11 Samsung Bioepis

About MarketResearchEngine.com
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging healthcare technologies, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.